OH Officials Warn Patients Of Potential Meningitis
Health officials in Ohio are reaching out to patients who received injections of a potentially contaminated steroid linked to a fungal meningitis outbreak that has killed seven people and sickened 91 across nine states.
The one Ohio case - involving a 65-year-old man who was sickened - was confirmed Saturday.
State and local health officials are working to ensure that all who received the epidural injections at four health care facilities in Ohio contact their doctors. The clinics are in Dublin, Cincinnati and Marion.
The Ohio Department of Health said Monday that the majority of patients have been contacted.
Some public health nurses and health commissioners have enlisted sheriffs' offices and emergency medical services workers to assist them. They say they will go door-to-door if necessary to reach the patients.
According to the ODH, the following Ohio clinics received the recalled medication which is frequently used to treat back pain:
BKC Pain Specialists, 1065 Delaware Ave., Marion, OH 43302
Marion Pain Clinic, 1199 Delaware Ave., Marion, OH 43302
Ortho-Spine Rehab Center, 7211 Sawmill Rd. Suite 101, Dublin, OH 43016
Cincinnati Pain Management, 8261 Cornell Rd., Cincinnati, OH 45249
Data showed that all the infected patients received injections with preservative-free methylprednisolone acetate (80mg/ml) prepared by the New England Compounding Center, located in Framingham, Mass.
The following lots are thought to be associated:
Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #05212012@68, BUD 11/17/2012
Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #06292012@26, BUD 12/26/2012
Methylprednisolone Acetate (PF) 80 mg/ml Injection, Lot #08102012@51, BUD 2/6/2013
Patients who received the steroid injection and who are experiencing symptoms such as new or worsening headaches, fever, neck stiffness or pain at the injection site, should contact their health care provided to determine if they have received one of the recalled products and to receive further evaluation